• Carmen Fontanez was named executive VP of payor sales and services for Access MediQuip (Houston). Previously, Fontanez was senior VP of sales and account management for CuraScript Pharmacy. Access MediQuip is a provider of outsourced medical implantable device management solutions.

• Holly Andersen, MD, has been appointed director of education and outreach at the new Ronald O. Perelman Heart Institute of New York-Presbyterian Hospital/ Weill Cornell Medical Center. The new position underscores the institute's commitment to raising awareness about the risks of heart disease. Considered to be a leading authority on preventive cardiology, Andersen will oversee patient education, community outreach and prevention efforts with the goal of reducing cardiovascular risk, especially among women. New York-Presbyterian Hospital announced in February 2008 the creation of the heart institute, made possible through a $50 million gift from Ronald Perelman that also created the Ronald O. Perelman and Claudia Cohen Center for Reproductive Medicine. The Perelman Heart Institute is scheduled to open this fall.

• Paul Ashton, PhD, has been named president/CEO of drug delivery company pSivida (Watertown, Massachusetts). Ashton joined pSivida in December 2005 following the acquisition of Control Delivery Systems (CDS), where he was co-founder/president/CEO. He was named managing director of pSivida in January 2007. Before co-founding CDS, Ashton was a joint faculty member in the Departments of Ophthalmology and Surgery at the University of Kentucky, served on the faculty of Tufts University and worked as a pharmaceutical scientist at Hoffman-LaRoche. pSivida is a developer of miniaturized, injectable, drug delivery systems for the eye.